We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK to Acquire Biotech Firm Corixa for $300 Million
GSK to Acquire Biotech Firm Corixa for $300 Million
May 2, 2005
GlaxoSmithKline (GSK) plans to acquire biotechnology firm Corixa for $300 million — a move that will bolster the British drug giant’s vaccine and antigen portfolios.